Manejo das disfunções temporomandibulares. Parte I: tratamento conservador
DOI:
https://doi.org/10.5335/rfo.v28i1.15194Palavras-chave:
Desordem temporomandibular, Dor orofacial, Tratamento conservadorResumo
Objetivo: Apresentar as modalidades de tratamentos conservadoras e minimamente invasivas mais usadas disponíveis no arsenal terapêutico das desordens temporomandibulares (DTM). Revisão da literatura: Os objetivos do tratamento invariavelmente incluem redução da dor, diminuição das atividades parafuncionais e restauração da função. Dentre as alternativas conservadoras e minimamente invasivas, podemos citar os dispositivos interoclusais, exercícios terapêuticos, eletrofototermoterapia, agulhamento seco e infiltração de anestésicos locais em pontos gatilho, injeção de sangue autógeno para controle da luxação mandibular, terapia cognitivo comportamental, toxina botulínica, viscossuplementação, controle farmacológico da dor aguda e crônica. As DTMs afetam uma proporção significativa da população. Somente após o fracasso das opções não invasivas é que devem ser iniciados tratamentos mais invasivos e irreversíveis. No entanto, algumas condições, como a anquilose e neoplasias, por exemplo, são essencialmente tratadas cirurgicamente e tentativas de tratamentos conservadores podem trazer piora na qualidade de vida ou risco de morte. Considerações finais: Uma abordagem de equipe multidisciplinar para o manejo é essencial no cuidado fundamental de todos os pacientes com DTM, para que o tratamento possa ser especificamente adaptado às necessidades individuais do paciente.
Downloads
Referências
Leeuw R de, Klasser GD. Orofacial Pain Guidelines for Assessment, Diagnosis, and Management. 6. ed. Quintessence Publishing Co; 2018.
Carlsson GE, Magnusson T, Guimarães AS. Tratamento das Disfunções Temporomandibulares na Clínica Odontológica. 1.·ed. Quintessence editora ltda; 2006.
Ohrbach R, Gonzalez Y, List T, Michelotti A, Schiffman E. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Clinical Examination Protocol: Version 02 [Internet]. 2013. Available from: www.rdc-tmdinternational.org
Ohrbach R E. Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments. [Internet]. 2016. Available from: www.rdc-tmdinternational.org
International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia 2020 Feb;40(2):129-221.
Goodwillie DH. Treatment of arthritis of the temporo-maxillary articulation. Arch Med 1881;5:259–63.
Dao TTT, Lavigne GJ. Oral splints: The crutches for temporomandibular disorders and bruxism. Crit Rev Oral Biol Med 1998;9(3):345–61.
Guimarães A. Dor Orofacial entre amigos - Uma discussão científica. Quintessence Editora ltda; 2012.
Greene CS, Menchel HF. The Use of Oral Appliances in the Management of Temporomandibular Disorders. Oral Maxillofac Surg Clin North Am 2018;30(3):265–77.
Wassell RW, Adams N, Kelly PJ. The treatment of temporomandibular disorders with stabilizing splints in general dental practice: one-year follow-up. J Am Dent Assoc 2006 Aug;137(8):1089-98.
Wassell RW, Adams N, Kelly PJ. Treatment of temporomandibular disorders by stabilising splints in general dental practice: Results after initial treatment. Br Dent J 2004;197(1):35-41.
Ramfjord SP, Ash MM. Reflections on the Michigan occlusal splint. J Oral Rehabil 1994 Sep;21(5):491-500.
Ekberg EC, Vallon D, Nilner M. Occlusal appliance therapy in patients with temporomandibular disorders: A double-blind controlled study in a short-term perspective. Acta Odontol Scand 1998;56(2):122–8.
Murakami KI, Kaneshita S, Kanoh C, Yamamura I. Ten-year outcome of nonsurgical treatment for the internal derangement of the temporomandibular joint with closed lock. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(5):572–5.
Dao TTT, Lavigne GJ, Charbonneau A, Feine JS, Lund JP. The efficacy of oral splints in the treatment of myofascial pain of the jaw muscles: a controlled clinical trial. Pain 1994;56(1):85–94.
Al-Moraissi EA, Farea R, Qasem KA, Al-Wadeai MS, Al-Sabahi ME, Al-Iryani GM. Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg 2020;49(8):1042–56.
de Leeuw JR, Steenks MH, Ros WJ, Lobbezoo-Scholte AM, Bosman F, Winnubst JA. Assessment of treatment outcome in patients with craniomandibular dysfunction. J Oral Rehabil 1994 Nov;21(6):655-66.
Eberhard D, Bantleon HP, Steger W. The efficacy of anterior repositioning splint therapy studied by magnetic resonance imaging. Eur J Orthod 2002;24(4):343–52.
Tecco S, Festa F, Salini V, Epifania E, D'Attilio M. Treatment of joint pain and joint noises associated with a recent TMJ internal derangement: a comparison of an anterior repositioning splint, a full-arch maxillary stabilization splint, and an untreated control group. Cranio 2004 Jul;22(3):209-19.
Pliska BT, Nam H, Chen H, Lowe AA, Almeida FR. Obstructive sleep apnea and mandibular advancement splints: Occlusal effects and progression of changes associated with a decade of treatment. J Clin Sleep Med 2014;10(12):1285–91.
Poluha RL, De La Torre Canales G, Costa YM, Grossmann E, Bonjardim LR, Conti PCR. Temporomandibular joint disc displacement with reduction: A review of mechanisms and clinical presentation. J Appl Oral Sci 2019;27:1–9.
Conti PCR, Dos Santos CN, Kogawa EM, Conti ACDCF, De Araujo CDRP. The treatment of painful temporomandibular joint clicking with oral splints: A randomized clinical trial. J Am Dent Assoc 2006;137(8):1108–14.
Paço M, Peleteiro B, Duarte J, Pinho T. The Effectiveness of Physiotherapy in the Management of Temporomandibular Disorders: A Systematic Review and Meta-analysis. J Oral Facial Pain Headache 2016;30(3):210–20.
de Melo L, de Medeiros A, Campos M, de Resende C, Barbosa G, de Almeida E. Manual Therapy in the Treatment of Myofascial Pain Related to Temporomandibular Disorders: A Systematic Review. J Oral Facial Pain Headache 2020;34(2):141–8.
Tenreiro M, Santos R. Terapia manual nas disfunções da ATM. Editora Rubio; 2018.
Sharman MJ, Cresswell AG, Riek S. Proprioceptive neuromuscular facilitation stretching: Mechanisms and clinical implications. Sport Med 2006;36(11):929–39.
Yoda T, Sakamoto I, Imai H, Honma Y, Shinjo Y, Takano A, et al. A randomized controlled trial of therapeutic exercise for clicking due to disk anterior displacement with reduction in the temporomandibular joint. Cranio 2003;21(1):10–6.
Mendonça LDM, Bittencourt NFN, Alves LEM, Resende RA, Serrão FV. Interventions used for Rehabilitation and Prevention of Patellar Tendinopathy in athletes: a survey of Brazilian Sports Physical Therapists. Brazilian J Phys Ther 2020;24(1):46–53.
Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Farooqui AA. Transcutaneous electric nerve stimulation (TENS) in dentistry- A review. J Clin Exp Dent 2014;6(5):e562–8.
Grossmann E, Tambara JS, Grossmann TK, Siqueira JTT. O uso da estimulação elétrica nervosa transcutânea na disfunção temporomandibular. Rev Dor 2012;13(3):271–6.
Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150(3699):971-9.
Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969 Apr 25;164(3878):444-5.
Gomez CE, Christensen LV. Stimulus-response latencies of two instruments delivering transcutaneous electrical neuromuscular stimulation (TENS). J Oral Rehabil 1991 Jan;18(1):87-94.
Dailey DL, Vance CGT, Rakel BA, Zimmerman MB, Embree J, Merriwether EN, Geasland KM, Chimenti R, Williams JM, Golchha M, Crofford LJ, Sluka KA. Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial. Arthritis Rheumatol 2020 May;72(5):824-836.
Esposito CJ, Veal SJ, Farman AG. Alleviation of myofascial pain with ultrasonic therapy. J Prosthet Dent 1984;51(1):106–8.
Ucar M, Sarp Ü, Koca Ä°, EroÄŸlu S, Yetisgin A, Tutoglu A, Boyacı A. Effectiveness of a home exercise program in combination with ultrasound therapy for temporomandibular joint disorders. J Phys Ther Sci 2014 Dec;26(12):1847-9.
Herpich CM, Leal-Junior ECP, Amaral AP, de Paiva Tosato J, dos Santos Glória IP, Garcia MBS, et al. Effects of phototherapy on muscle activity and pain in individuals with temporomandibular disorder: A study protocol for a randomized controlled trial. Trials 2014;15(1):1–8.
Marini I, Gatto MR, Bonetti GA. Effects of superpulsed low-level laser therapy on temporomandibular joint pain. Clin J Pain 2010;26(7):611–6.
Cunha LA, Firoozmand LM, da Silva AP, Camargo SE, Oliveira W. Efficacy of low-level laser therapy in the treatment of temporomandibular disorder. Int Dent J 2008 Aug;58(4):213-7.
Emshoff R, Bösch R, Pümpel E, Schöning H, Strobl H. Low-level laser therapy for treatment of temporomandibular joint pain: a double-blind and placebo-controlled trial. Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology 2008;105(4):452–6.
Manfredini D, Ahlberg J, Winocur E, Guarda-Nardini L, Lobbezoo F. Correlation of RDC/TMD axis I diagnoses and axis II pain-related disability. A multicenter study. Clin Oral Investig 2011;15(5):749–56.
Leite FM, Atallah AN, El Dib R, Grossmann E, Januzzi E, Andriolo RB, da Silva EM. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev 2009;2009(3):CD006830.
Al-Moraissi EA, Alradom J, Aladashi O, Goddard G, Christidis N. Needling therapies in the management of myofascial pain of the masticatory muscles: A network meta-analysis of randomised clinical trials. J Oral Rehabil 2020 Jul;47(7):910-922.
Simons DG TJ SP. The Trigger Point Manual. Upper Half of Body. 2. ed. Balt MD Williams Wilkins; 1999;Vol 1.
Gerwin RD, Shannon S, Hong CZ, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain 1997;69(1–2):65–73.
Desai MJ, Saini V, Saini S. Myofascial Pain Syndrome: A Treatment Review. Pain Ther 2013;2(1):21–36.
Casanueva B, Rivas P, Rodero B, Quintial C, Llorca J, González-Gay MA. Short-term improvement following dry needle stimulation of tender points in fibromyalgia. Rheumatol Int 2014;34(6):861–6.
Speed CA. Injection therapies for soft-tissue lesions. Best Pract Res Clin Rheumatol 2007;21(2):333–47.
Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85(1–2):101–5.
Ho KY, Tan KH. Botulinum toxin A for myofascial trigger point injection: A qualitative systematic review. Eur J Pain 2007;11(5):519–27.
Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil 1994 Jul-Aug;73(4):256-63.
Edwards J, Knowles N. Superficial Dry Needling and Active Stretching in the Treatment of Myofascial Pain - A Randomised Controlled Trial. Acupunct Med 2003;21(3):80–6.
Borg-Stein J. Treatment of Fibromyalgia, Myofascial Pain, and Related Disorders. Phys Med Rehabil Clin N Am 2006;17(2):491–510.
Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: A systematic review. Arch Phys Med Rehabil 2001;82(7):986–92.
Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayık Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005;25(8):604–11.
Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L. Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. PM R 2015 Jul;7(7):746-761.
Candirli C, Yüce S, Cavus UY, Akin K, Cakir B. Autologous blood injection to the temporomandibular joint: Magnetic resonance imaging findings. Imaging Sci Dent 2012;42(1):13–8.
Machon V, Abramowicz S, Paska J, Dolwick MF. Autologous Blood Injection for the Treatment of Chronic Recurrent Temporomandibular Joint Dislocation. J Oral Maxillofac Surg 2009;67(1):114–9.
O’Driscoll SW GN. Continuous passive motion (CPM): Theory and principles of clinical application. J Rehabil Res Dev 2000;37(2):179-88.
Coser R, Da Silveira H, Medeiros P, Ritto FG. Autologous blood injection for the treatment of recurrent mandibular dislocation. Int J Oral Maxillofac Surg 2015;44(8):1034–7.
Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999;42(5):1033-9.
Hasson O, Nahlieli O. Autologous blood injection for treatment of recurrent temporomandibular joint dislocation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92(4):390–3.
Varedi P, Bohluli B. Autologous blood injection for treatment of chronic recurrent TMJ dislocation: is it successful? Is it safe enough? A systematic review. Oral Maxillofac Surg 2015;19(3):243–52.
Eliis A. Reason and Emotion in Psychotherapy. New York - Birch Lane; 1994.
Sharav Y, Benoliel R. Dor Orofacial e Cefaleias. 2. ed. Quintessence Editora ltda; 2017.
Turner JA, Mancl L, Aaron LA. Short- and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: a randomized, controlled trial. Pain 2006;121(3):181–94.
Emiko Morishige, Shoichi Ishigaki, Hirofumi Yatani MH. Clinical effectiveness of cognitive behavior therapy in the management of TMD. Int J Prosthodont 2006;19(1):31-3.
Walen S, DiGiuseppe R, Dryden W. A Practitioner’s Guide do Rational-Emotive Therapy. 2. ed. New York - Oxford University; 1992.
Wenzel RG. Pharmacology of botulinum neurotoxin serotype A. Am J Heal Pharm 2004;61(suppl. 6):5–10.
Unno EK, Sakata RK, Issy AM. Estudo comparativo entre toxina botulínica e bupivacaína para infiltração de pontos-gatilho em síndrome miofascial crônica. Rev Bras Anestesiol 2005;55(2):250–5.
Matak I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol 2014;119–120:39–59.
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005;26(5):785–93.
Mor N, Tang C, Blitzer A. Temporomandibular myofacial pain treated with botulinum toxin injection. Toxins (Basel) 2015;7(8):2791–800.
De la Torre Canales G, Alvarez-Pinzon N, Muñoz-Lora VRM, Vieira Peroni L, Farias Gomes A, Sánchez-Ayala A, Haiter-Neto F, Manfredini D, Rizzatti-Barbosa CM. Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial. Toxins (Basel) 2020;12(6):395.
Freund B, Schwartz M, Symington JM. Botulinum toxin: New treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 2000;38(5):466–71.
Soares A, Andriolo RB, Atallah ÁN, da Silva EMK. Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev 2014;2014(7):CD007533.
Göbel H, Heinze A, Reichel G, Hefter H, Benecke R. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo-controlled multicentre study. Pain 2006;125(1–2):82–8.
Muñoz Lora VRM, Del Bel Cury AA, Jabbari B, Lacković Z. Botulinum Toxin Type A in Dental Medicine. J Dent Res 2019;98(13):1450–7.
Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord 2013;28(13):1775–83.
De la Torre Canales G, Poluha RL, Lora VM, Araújo Oliveira Ferreira DM, Stuginski-Barbosa J, Bonjardim LR, Cury AADB, Conti PCR. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? Clin Oral Investig 2019 Sep;23(9):3411-3421.
Raphael KG, Tadinada A, Bradshaw JM, Janal MN, Sirois DA, Chan KC, Lurie AG. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study. J Oral Rehabil 2014;41(8):555-63.
Lee HJ, Kim SJ, Lee KJ, Yu HS, Baik HS. Repeated injections of botulinum toxin into the masseter muscle induce bony changes in human adults: A longitudinal study. Korean J Orthod 2017;47(4):222–8.
Matthys T, Ho Dang HA, Rafferty KL, Herring SW. Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin. Am J Orthod Dentofac Orthop 2015;148(6):999–1009.
Rafferty KL, Liu ZJ, Ye W, Navarrete AL, Nguyen TT, Salamati A, Herring SW. Botulinum toxin in masticatory muscles: short- and long-term effects on muscle, bone, and craniofacial function in adult rabbits. Bone 2012 Mar;50(3):651-62.
Wei L, Xiong H, Li B, Gong Z, Li J, Cai H, et al. Change of HA molecular size and boundary lubrication in synovial fluid of patients with temporomandibular disorders. J Oral Rehabil 2010;37(4):271–7.
Sequeira J, Rao BHS, Kedia PR. Efficacy of Sodium Hyaluronate for Temporomandibular Joint Disorder by Single-Puncture Arthrocentesis. J Maxillofac Oral Surg 2019 Mar;18(1):88-92.
Ghosh P, Guidolin D. Potential Mechanism of Action of Intra-articular Hyaluronan Therapy in Osteoarthritis: Are the Effects Molecular Weight Dependent? Semin Arthritis Rheum 2002;32(1):10–37.
Gibbs DA, Merrill EW, Smith KA BE. Rheology of hyaluronic acid. Biopolymers 1968;(6):777–91.
Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 2000;8(5):277–84.
Clegg TE, Caborn D, Mauffrey C. Viscosupplementation with hyaluronic acid in the treatment for cartilage lesions: A review of current evidence and future directions. Eur J Orthop Surg Traumatol 2013;23(2):119–24.
Takahashi T, Tominaga K, Takano H, Ariyoshi W, Habu M, Fukuda J, et al. A decrease in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders. J Oral Pathol Med 2004;33(4):224–9.
Hepguler S, Akkoc YS, Pehlivan M, Ozturk C, Celebi G, Saracoglu A, et al. The efficacy of intra-articular sodium hyaluronate in patients with reducing displaced disc of the temporomandibular joint. J Oral Rehabil 2002;29(1):80–6.
Forster H, Fisher J. The influence of loading time and lubricant on the friction of articular cartilage. Proc Inst Mech Eng Part H J Eng Med 1996;210(2):109–18.
Nitzan DW, Nitzan U, Dan P, Yedgar S. The role of hyaluronic acid in protecting surface-active phospholipids from lysis by exogenous phospholipase A2. Rheumatology 2001;40(3):336–40.
Tanaka E, Kawai N, Hanaoka K, Van Eijden T, Sasaki A, Aoyama J, et al. Shear properties of the temporomandibular joint disc in relation to compressive and shear strain. J Dent Res 2004;83(6):476–9.
Merry P, Winyard PG, Morris.M CJ, Grootveld M, Blake DR. Oxygen free radicals, inflammation, and synovitis: And synovitis: The current status. Ann Rheum Dis 1989;48(10):864–70.
Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J 1991;273(2):459–67.
Nitzan DW. The process of lubrication impairment and its involvement in temporomandibular joint dics displacement. A theoretical concept. J Oral Maxillofac Surg 2001;59(1):36–45.
Butler J, Rydell NW, Balazs EA. Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet Scand 1970;11(2):139-55.
Kopp S, Wenneberg B. Effects of occlusal treatment and intraarticular injections on temporomandibular joint pain and dysfunction. Acta Odontol Scand 1981;39(2):87–96.
Alpaslan C, Bilgihan A, Alpaslan GH, Güner B, Ozgür Yis M, ErbaÅŸ D. Effect of arthrocentesis and sodium hyaluronate injection on nitrite, nitrate, and thiobarbituric acid-reactive substance levels in the synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(6):686–90.
Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D. Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2012;70(11):2522–30.
Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980 Jul;40(3):435-46.
Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S. The influence of intra-articular hyal- uronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989;7(3):247–50.
Tobetto K, Yasui T, Ando T, Hayaishi M, Motohashi N, Shinogi M, Mori I. Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 1992 Oct;60(2):79-84.
Patel P, Idrees F, Newaskar V, Agrawal D. Sodium hyaluronate: an effective adjunct in temporomandibular joint arthrocentesis. Oral Maxillofac Surg 2016;20(4):405–10.
Guarda-Nardini L, Rossi A, Arboretti R, Bonnini S, Stellini E, Manfredini D. Single- or multiple-session viscosupplementation protocols for temporomandibular joint degenerative disorders: A randomized clinical trial. J Oral Rehabil 2015;42(7):521–8.
Kopp S, Akerman S, Nilner M. Short-term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporomandibular joint. Craniomandib Disord 1991;5(4):231–8.
Zhang ZK, Ma XC, Gao S, Gu ZY, Fu KY. Studies on contributing factors in temporomandibular disorders. Chin J Dent Res 1999;2(3-4):7-20.
Thein R, Haviv B, Kidron A, Bronak S. Intra-articular injection of hyaluronic acid following arthroscopic partial meniscectomy of the knee. Orthopedics 2010 Oct 11;33(10):724.
Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American Heart Association. Circulation 2007;115(12):1634-42.
Mcgettigan P, Lincz LF, Attia J, Mcelduff P, Bissett L, Peel R, et al. The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene. Br J Clin Pharmacol 2011;72(4):707–14.
Jüni P, Reichenbach S, Egger M. COX 2 inhibitors, traditional NSAIDs, and the heart. Br Med J 2005;330(7504):1342–3.
Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Br Med J 2006;332(7553):1302–5.
Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, et al. ACCF/ACG/AHA. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010 Dec 7;56(24):2051-66.
Ekberg E. Treatment of temporomandibular disorders of arthrogeneous origin. Controlled double-blind studies of a non-steroidal anti-inflammatory drug and a stabilisation appliance. Swed Dent J Suppl 1998;131:1-57.
Thie NM, Prasad NG, Major PW. Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial. J Rheumatol 2001;28(6):1347–55.
Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992 May 7;326(19):1250-6.
Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: A comprehensive review. Expert Rev Neurother 2015;15(10):1123–50.
Haviv Y, Zini A, Sharav Y, Almoznino G, Benoliel R. Nortriptyline Compared to Amitriptyline for the Treatment of Persistent Masticatory Myofascial Pain. J Oral Facial Pain Headache 2019;33(1):7–13.
Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, Lunn MP, Hamunen K, Haanpaa M, Kalso EA. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev 2013;2013(11):CD010567.
Chang WJ. Muscle Relaxants for Acute and Chronic Pain. Phys Med Rehabil Clin N Am 2020;31(2):245–54.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2023 Revista da Faculdade de Odontologia - UPF
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Este periódico bem como seus artigos estão licenciados com a licença Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional.
